Information Provided By:
Fly News Breaks for March 4, 2020
MRNA
Mar 4, 2020 | 07:44 EDT
Morgan Stanley analyst Matthew Harrison noted that the head of the National Institute for Allergy and Infectious Disease, Dr. Anthony Fauci, indicated that dosing of the first patient for Moderna's COVID-19 vaccine candidate would be "soon," adding that he would expect an announcement from the NIAID around first patient dosing. Fauci had originally indicated he did not expect first patient dosing until late April, so this update is about 1.5 months ahead of schedule, said Harrison, who has an Overweight rating and $30 price target on Moderna.
News For MRNA From the Last 2 Days
MRNA
Apr 19, 2021 | 12:35 EDT
IBM (IBM) is scheduled to report results of its fiscal first quarter after the market close on April 19, with a conference call scheduled for 5:00 pm ET. What to watch... To see the rest of the story go to thefly.com. See Story Here